2006 Annual Meeting | Clinical Research Methods

Date Monday 04/03/06

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) S. C. Johnston, MD, PhD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should be able to apply principles of clinical research to practice, investigation, and interpretation of the literature. In addition, they will be able to better select avenues for more advanced training in clinical research methods.

CME Available No CME available

Core Competencies Professionalism, Medical Knowledge, Systems-based Practice

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:45 AM		Randomized Clinical Trials Karl D. Kieburtz, MD
09:45 AM - 10:30 AM		Observational Studies Daniel Woo, MD, FAAN
10:30 AM - 10:45 AM		Discussion
10:45 AM - 11:00 AM		Break
11:00 AM - 11:45 AM		Sampling and Measurement Biases Walter A. Rocca, MD, MPH
11:45 AM - 12:00 PM		Discussion
12:00 PM - 01:15 PM		Lunch
01:15 PM - 02:00 PM		Random Error, Confounding, and Effect Modification George Howard, PhD
02:00 PM - 02:45 PM		Health Services Research: Quality of Care and Outcomes Research Michael D. Hill, MD
02:45 PM - 03:00 PM		Discussion
03:00 PM - 03:15 PM		Break
03:15 PM - 04:00 PM		Developing Tools for Evidence-Based Medicine S. C. Johnston, MD, PhD, FAAN
04:00 PM - 03:45 PM		Legal and Ethical Issues in Clinical Research Edward Goldman, JD
04:45 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
S. C. Johnston, MD, PhD, FAAN	No disclosure on file
Karl D. Kieburtz, MD	Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Walter A. Rocca, MD, MPH	The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
Michael D. Hill, MD	Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular.
George Howard, PhD	Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Edward Goldman, JD	No disclosure on file

��ɫ��

��ɫ��